Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
Australia
/ epidemiology
Canada
/ epidemiology
Equipment Design
Europe
/ epidemiology
Female
Follow-Up Studies
Heart Failure
/ mortality
Heart Ventricles
/ physiopathology
Heart-Assist Devices
Humans
Kazakhstan
/ epidemiology
Male
Middle Aged
Prospective Studies
Stroke Volume
/ physiology
Survival Rate
/ trends
Time Factors
Treatment Outcome
United States
/ epidemiology
Heart failure
HeartMate 3
Left ventricular assist system
Magnetic levitation
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
05
12
2017
revised:
11
06
2018
accepted:
26
06
2018
pubmed:
28
7
2018
medline:
22
5
2019
entrez:
28
7
2018
Statut:
ppublish
Résumé
This study aimed to assess safety and outcomes of patients, 2 years after implantation with the HeartMate 3 Left Ventricular Assist System. This study included 50 adults with New York Heart Association (NYHA) class IIIB or IV symptoms or American College of Cardiology/American Heart Association stage D heart failure with an ejection fraction ≤25% and a cardiac index ≤2.2 L/min/m Two years post-HeartMate 3 implantation, results show expected and acceptable survival, enhanced haemocompatibility, improved patient functional status and quality of life. This corroborates the success of HeartMate 3 since its first-in-man implantation case in Germany. ClinicalTrials.gov: NCT02170363.
Banques de données
ClinicalTrials.gov
['NCT02170363']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
90-97Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.